Which of the following is NOT an example of apoptosis?
Lordotic spleen is seen in which of the following conditions?
Antitumor activity is shown by all except?
Which of the following is essential for tumor metastasis?
Which of the following is not true about apoptosis?
What are the potential complications that can arise from a dentigerous cyst?
The highest ESR is seen in which of the following conditions except?
Lardaceous spleen is due to deposition of amyloid in which part?
What is apoptosis?
Perl's stain or Prussian blue test is used for the detection of which substance?
Explanation: **Explanation:** Apoptosis is a form of programmed cell death characterized by enzymatic degradation of proteins and DNA, mediated by caspases [2]. It occurs in both physiological and pathological conditions without inducing an inflammatory response [4]. **Why "None of the above" is correct:** All three options (A, B, and C) are classic examples of apoptosis. Since the question asks for which is *NOT* an example, and all are examples, "None of the above" is the correct choice. **Analysis of Options:** * **A. Graft versus Host Disease (GVHD):** In GVHD and cellular rejection, cytotoxic T-lymphocytes induce apoptosis in target cells via the **Perforin/Granzyme pathway**, which directly activates caspases. * **B. Menstrual Cycle:** This is a classic example of **Physiological Apoptosis** [3]. The withdrawal of hormones (progesterone) leads to the breakdown of the endometrial lining through apoptotic pathways [3]. * **C. Pathological Atrophy following duct obstruction:** When ducts in organs like the pancreas, parotid gland, or kidney are obstructed, the resulting parenchymal atrophy occurs via apoptosis. **NEET-PG High-Yield Pearls:** 1. **Morphology:** The hallmark of apoptosis is **chromatin condensation** (pyknosis) and the formation of apoptotic bodies. The cell membrane remains intact (unlike necrosis). 2. **Biochemical Marker:** Presence of **Phosphatidylserine** on the outer leaflet of the plasma membrane (flipped from the inner leaflet) serves as an "eat-me" signal for phagocytes [4]. 3. **DNA Pattern:** On electrophoresis, apoptosis shows a characteristic **"Step-ladder pattern"** due to internucleosomal DNA cleavage by Ca²⁺/Mg²⁺ dependent endonucleases. 4. **Key Gene:** **BCL-2** is anti-apoptotic (stabilizes mitochondrial membrane), while **BAX and BAK** are pro-apoptotic [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 67-69.
Explanation: The correct answer is **Diffuse amyloidosis (Option D)**. In systemic amyloidosis, the spleen is a frequently involved organ [1]. Depending on the pattern of amyloid deposition, two distinct macroscopic appearances are observed: 1. **Sago Spleen (Focal Amyloidosis):** Amyloid is deposited primarily in the **splenic follicles** (white pulp). Macroscopically, these appear as pale, translucent, grain-like granules resembling sago (tapioca). 2. **Lardaceous Spleen (Diffuse Amyloidosis):** Amyloid deposition occurs predominantly in the **splenic sinuses and red pulp** [3]. Over time, these deposits coalesce, giving the organ a firm, waxy, and map-like appearance. The term "lardaceous" (or "lordotic" in some older texts/transliterations) refers to its resemblance to **lard** (pig fat). **Analysis of Incorrect Options:** * **Alcoholic & Chronic Active Hepatitis (Options A & B):** These conditions primarily affect the liver. While they can cause portal hypertension leading to **congestive splenomegaly**, they do not produce the specific "lardaceous" or "sago" patterns characteristic of amyloid deposition. * **Focal Amyloidosis (Option C):** As mentioned, focal deposition results in "Sago Spleen," not the diffuse lardaceous (lordotic) form. **High-Yield Pearls for NEET-PG:** * **Staining:** Amyloid is identified by **Congo Red** stain, showing **apple-green birefringence** under polarized light [2]. * **Sago Spleen:** White pulp involvement (Focal). * **Lardaceous Spleen:** Red pulp involvement (Diffuse) [3]. * **Most common site of amyloidosis:** Kidney (most common cause of death) or Spleen (most common organ involved macroscopically) [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 135-136. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-266. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140.
Explanation: The host immune response against tumors involves both innate and adaptive immunity, primarily mediated by cells capable of recognizing tumor-specific antigens or altered cell-surface markers. [1] **Why Basophils are the Correct Answer:** Basophils are granulocytes primarily involved in **Type I hypersensitivity reactions** (allergic responses) and defense against helminthic parasites. They release histamine, leukotrienes, and heparin upon IgE-mediated activation. Unlike other leukocytes, basophils do not possess significant cytotoxic or phagocytic mechanisms to target neoplastic cells, making them the only option listed without established antitumor activity. **Analysis of Other Options:** * **Cytotoxic T Lymphocytes (CTLs/CD8+):** These are the **most important** cells for antitumor immunity. They recognize tumor antigens presented by MHC Class I molecules and induce apoptosis via the Perforin-Granzyme pathway. [1] * **Natural Killer (NK) Cells:** These are the first line of defense. They destroy tumor cells that attempt "immune escape" by downregulating MHC Class I expression (which would otherwise hide them from CTLs). [1] * **Macrophages:** Activated macrophages (specifically the **M1 phenotype**) exhibit antitumor activity by secreting Tumor Necrosis Factor (TNF) and reactive oxygen species (ROS), as well as by phagocytosing tumor cells. [1] **High-Yield Clinical Pearls for NEET-PG:** * **Most potent antitumor cell:** CD8+ Cytotoxic T cell. [1] * **Immune Surveillance:** The process by which the immune system identifies and destroys nascent tumors; deficiencies in this system (e.g., AIDS) lead to increased cancer risk. [1] * **Cytokine Profile:** IL-12 and IFN-gamma are the primary cytokines that enhance the antitumor activity of NK cells and CTLs. * **Tumor-Infiltrating Lymphocytes (TILs):** The presence of these cells in a biopsy is often a positive prognostic factor in many cancers (e.g., Melanoma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 318-322.
Explanation: **Explanation:** **Why Angiogenesis is Correct:** For a tumor to grow beyond 1–2 mm in diameter and eventually metastasize, it must develop its own blood supply [1]. This process, known as **angiogenesis**, is essential for two reasons: 1. **Nutrient Supply:** It provides the oxygen and nutrients required for the primary tumor to expand [4]. 2. **Route of Escape:** Newly formed tumor vessels are often "leaky" and have fragmented basement membranes, providing an easy entry point (intravasation) for tumor cells to enter the systemic circulation and spread to distant organs [3]. This is regulated by the "angiogenic switch," primarily driven by **VEGF** (Vascular Endothelial Growth Factor) [1]. **Analysis of Incorrect Options:** * **B. Tumorogenesis:** This refers to the initial formation/transformation of normal cells into cancer cells. While it is the starting point of cancer, it does not guarantee metastasis; many benign tumors undergo tumorigenesis but never metastasize. * **C. Apoptosis:** This is programmed cell death. Metastatic cells actually need to **evade** apoptosis (especially *anoikis*, which is death induced by loss of cell adhesion) to survive during transit in the blood [2]. * **D. Inhibition of Tyrosine kinase activity:** Many growth factor receptors are tyrosine kinases. Inhibiting them (e.g., using Imatinib) usually **prevents** tumor growth and spread rather than being essential for it. **High-Yield NEET-PG Pearls:** * **HIF-1α** (Hypoxia-inducible factor) is the primary sensor of hypoxia that triggers VEGF production [1]. * **Thrombospondin-1** is a potent innate inhibitor of angiogenesis. * **VHL Protein:** Acts as a tumor suppressor by degrading HIF-1α; its mutation leads to Von Hippel-Ludlau disease (characterized by highly vascular tumors like hemangioblastomas). * **Sentinel Lymph Node Biopsy:** The most common clinical method to assess the earliest stage of lymphatic metastasis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 313-314. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 233-234. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 314-315. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 203-204.
Explanation: **Explanation:** Apoptosis is defined as "programmed cell death," a tightly regulated process where the cell activates enzymes that degrade its own DNA and proteins [1]. **Why Option A is the Correct Answer:** The hallmark of apoptosis is that it **does not elicit an inflammatory response** [1]. Unlike necrosis, where the plasma membrane ruptures and spills cellular contents into the extracellular space (triggering neutrophils and inflammation), in apoptosis, the plasma membrane remains **intact**. The cell breaks into membrane-bound "apoptotic bodies" which are rapidly cleared by macrophages before their contents can leak out. Therefore, the presence of inflammation is characteristic of necrosis, not apoptosis [1]. **Analysis of Incorrect Options:** * **Option B (Bleb formation):** This is a classic morphological feature. The cytoskeleton undergoes reorganization, leading to protrusions of the cell membrane known as "zeiosis" or blebbing. * **Option C (Eosinophilia):** As the cell shrinks and the cytoplasm becomes concentrated, combined with the loss of cytoplasmic RNA (which is basophilic), the cell stains more intensely pink with H&E stain (increased eosinophilia). * **Option D (Cell shrinkage):** This is the earliest morphological change in apoptosis. The cell size reduces and organelles become more tightly packed, contrasting with the cell swelling (oncosis) seen in necrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Most characteristic feature:** Chromatin condensation (Pyknosis). * **Gold standard for detection:** DNA Laddering on electrophoresis (due to internucleosomal cleavage by endonucleases into 180-200 bp fragments). * **Key Enzyme:** Caspases (Cysteine-dependent Aspartate-specific proteases) [1]. * **Anti-apoptotic genes:** BCL-2, BCL-XL, MCL-1 [2]. * **Pro-apoptotic genes:** BAX, BAK [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-69. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 80-81.
Explanation: A **dentigerous cyst** (follicular cyst) is the most common type of developmental odontogenic cyst [1], arising from the separation of the follicle from around the crown of an unerupted tooth. The cyst is lined by **reduced enamel epithelium**, which possesses significant multipotentiality. This pluripotential nature of the epithelial lining is the underlying reason why various neoplastic transformations can occur within the cyst wall. **Why "All of the above" is correct:** The epithelial lining of a dentigerous cyst can undergo neoplastic transformation into: * **Ameloblastoma:** This is the most common neoplastic complication. The lining cells can transform into odontogenic epithelium, leading to a "unicystic ameloblastoma." * **Squamous Cell (Epidermoid) Carcinoma:** Chronic inflammation or long-standing irritation can trigger malignant transformation of the stratified squamous lining. * **Mucoepidermoid Carcinoma:** Since the lining contains mucous-secreting cells (goblet cells) in about 40% of cases (prosoplasia), it can rarely give rise to this salivary gland-type malignancy. **Clinical Pearls for NEET-PG:** * **Radiological Hallmark:** Appears as a well-defined unilocular radiolucency attached to the **cemento-enamel junction (CEJ)** of an unerupted tooth (most commonly the mandibular 3rd molar). * **Pathogenesis:** Accumulation of fluid between the reduced enamel epithelium and the tooth crown. * **Treatment:** Standard treatment is enucleation; however, histopathological examination is mandatory to rule out the aforementioned neoplastic changes. * **Key Association:** If a radiolucency around a crown exceeds **3-4 mm**, a dentigerous cyst should be suspected over a normal dental follicle. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, p. 741.
Explanation: The **Erythrocyte Sedimentation Rate (ESR)** is a non-specific marker of inflammation that measures the rate at which red blood cells (RBCs) sink in a column of anticoagulated blood. **Why Polycythemia Rubra is the correct answer:** ESR is inversely proportional to the concentration of RBCs. In **Polycythemia rubra vera**, there is a significant increase in the number of RBCs (high hematocrit) [4], [5]. This crowding of cells increases the internal friction and viscosity of the blood, which physically hinders the downward settling of erythrocytes. Consequently, the ESR is characteristically **very low or near zero**. **Analysis of Incorrect Options:** * **Multiple Myeloma:** This condition involves a massive production of monoclonal immunoglobulins (paraproteins) [1], [3]. These proteins neutralize the negative surface charge of RBCs (zeta potential), promoting **Rouleaux formation** [1], [2]. Larger aggregates sediment much faster, leading to a markedly elevated ESR (often >100 mm/hr). * **Temporal Arteritis & Polymyalgia Rheumatica:** These are systemic inflammatory vasculitides. The intense acute-phase response increases fibrinogen levels, which significantly accelerates RBC sedimentation. A highly elevated ESR is a key diagnostic criterion for both conditions. **NEET-PG High-Yield Pearls:** * **Highest ESR (>100 mm/hr):** Seen in Multiple Myeloma, Temporal Arteritis, Metastatic Malignancy, and Severe Infections (e.g., Tuberculosis). * **Low/Zero ESR:** Seen in Polycythemia, Sickle cell anemia (abnormal shape prevents Rouleaux), Afibrinogenemia, and Spherocytosis. * **Factors increasing ESR:** Anemia (fewer cells to resist sinking), pregnancy, and old age. * **Westergren Method** is the gold standard for measuring ESR. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 607-608. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 617-618. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 266-267. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 663-664. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-615.
Explanation: **Explanation:** Amyloidosis of the spleen presents in two distinct patterns depending on the site of deposition: **Sago Spleen** and **Lardaceous Spleen** [1]. **1. Why Option A is Correct:** In **Lardaceous Spleen**, amyloid is primarily deposited in the **walls of the splenic sinusoids and the connective tissue framework of the red pulp**. As the deposition progresses, it involves the splenic cords, leading to massive splenomegaly. Grossly, the spleen appears firm with a "map-like" or "lard-like" (waxy/fatty) appearance on the cut surface, which gives it the name "lardaceous." **2. Why the Other Options are Incorrect:** * **Option B (White Pulp):** Amyloid deposition limited to the splenic follicles (white pulp) results in **Sago Spleen**. Grossly, this appears as small, pale, translucent grains resembling sago (tapioca) [1]. * **Option C (Parenchymal Artery):** While amyloid can involve vessel walls, isolated arterial involvement is not the defining feature of the lardaceous pattern [1]. * **Option D (Splenic Trabeculae):** Amyloid does not preferentially deposit in the fibrous trabeculae; it targets the functional parenchyma (pulp). **High-Yield Clinical Pearls for NEET-PG:** * **Staining:** Amyloid shows **Apple-green birefringence** under polarized light when stained with **Congo Red** [1]. * **Sago vs. Lardaceous:** Remember **S**ago = **S**plenic follicles (White pulp); **L**ardaceous = **R**ed pulp (mnemonic: **L**arge = **L**ardaceous, as it causes more significant splenomegaly). * **Most common organ involved:** Kidney is the most common organ involved in systemic amyloidosis, but the spleen is a very frequent site. * **Precursor Protein:** In secondary amyloidosis (AA), the spleen is frequently involved [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 264-269.
Explanation: **Explanation:** **Apoptosis** is a pathway of cell death induced by a tightly regulated intracellular program [1]. It is often referred to as **"programmed cell death"** or "cell suicide." Unlike necrosis, it is an **internally controlled** process where the cell activates enzymes (caspases) that degrade its own nuclear DNA and cytoplasmic proteins while keeping the plasma membrane intact [2]. This ensures the cell is removed without eliciting an inflammatory response. **Analysis of Options:** * **Option A (Correct):** Apoptosis is "internally controlled" because it relies on intrinsic genetic programming and intracellular machinery (like the mitochondria-mediated pathway) [2] to execute death. * **Option B:** While external signals (like Fas-ligand) [3] can trigger the extrinsic pathway, the actual execution is an internal, self-driven molecular program. "Externally controlled" usually refers to accidental cell death like necrosis caused by toxins or ischemia. * **Option C:** While enzymes (caspases) are involved, the end result is the death of the entire cell, not just the degradation of enzymes [2]. * **Option D:** Karyolysis (nuclear fading) is a hallmark of **necrosis**, not apoptosis. In apoptosis, the nucleus undergoes **pyknosis** (shrinkage) and **karyorrhexis** (fragmentation). **NEET-PG High-Yield Pearls:** * **Morphology:** Cell shrinkage, chromatin condensation (most characteristic), and formation of **apoptotic bodies**. * **Key Enzymes:** **Caspases** (Cysteine aspartic acid-specific proteases) [2]. Caspase-3 is the main executioner. * **Marker:** **Annexin V** is used to identify apoptotic cells (it binds to Phosphatidylserine shifted to the outer membrane). * **No Inflammation:** This is the most crucial distinction from necrosis [1]. * **Energy Dependent:** Apoptosis requires ATP, whereas necrosis does not. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 67.
Explanation: **Explanation:** **Perl’s Prussian Blue** is a histochemical reaction used specifically to detect **ferric iron ($Fe^{3+}$)** in tissues. [1] 1. **Why Hemosiderin is correct:** Hemosiderin is an intracellular protein-bound iron complex derived from the breakdown of hemoglobin [2]. In this reaction, the tissue is treated with a mixture of potassium ferrocyanide and hydrochloric acid. The acid releases the ferric iron from the protein, which then reacts with the ferrocyanide to form **ferric ferrocyanide**, a bright blue (Prussian blue) precipitate [1]. This is the gold standard for diagnosing iron overload states like **hemochromatosis** and **hemosiderosis**. 2. **Why other options are incorrect:** * **Bilirubin:** Detected using the **Fouchet’s stain** (turns green due to oxidation to biliverdin) [2]. * **Calcium:** Detected using **Von Kossa stain** (black) or **Alizarin Red S** (orange-red). * **Glycogen:** Detected using **PAS (Periodic Acid-Schiff)** stain; it is diastase-sensitive [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Heart Failure Cells:** Perl’s stain identifies hemosiderin-laden macrophages in the alveoli, indicating chronic pulmonary congestion [4]. * **Sideroblastic Anemia:** Used to visualize **Ringed Sideroblasts** (iron in mitochondria) in bone marrow aspirates. * **Differentiation:** It helps differentiate "wear and tear" pigment (**Lipofuscin**, which is Perl's negative) from iron pigment [3]. * **Note:** Perl’s stain does **not** react with ferrous iron ($Fe^{2+}$) or iron tightly bound in hemoglobin/myoglobin. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 75-76. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 75. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 639-640.
Cell Injury and Cell Death
Practice Questions
Adaptations of Cellular Growth
Practice Questions
Accumulations and Deposits
Practice Questions
Acute and Chronic Inflammation
Practice Questions
Tissue Repair and Wound Healing
Practice Questions
Hemodynamic Disorders
Practice Questions
Genetic Disorders
Practice Questions
Environmental Pathology
Practice Questions
Nutritional Diseases
Practice Questions
Molecular Basis of Disease
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free